Inhibition by erythromycin of the conversion of carbamazepine to its active 10,11‐epoxide metabolite.
Open Access
- 1 December 1987
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 24 (6) , 836-838
- https://doi.org/10.1111/j.1365-2125.1987.tb03257.x
Abstract
The serum levels of carbamazepine (CBZ) and its 10,11‐epoxide metabolite (CBZ‐E) were determined in seven subjects after a single dose of CBZ (400 mg) in the control state and during co‐administration of erythromycin (500 mg three times daily for 10 days). Erythromycin treatment was associated with a decrease in CBZ clearance and a prolongation of CBZ half‐life, while CBZ‐E levels were markedly reduced. These data provide evidence that erythromycin inhibits the conversion of CBZ to its epoxide metabolite.This publication has 21 references indexed in Scilit:
- INTERACTION BETWEEN CARBAMAZEPINE AND PROPOXYPHENE IN MANActa Neurologica Scandinavica, 2009
- Carbamazepine-Danazol Drug InteractionTherapeutic Drug Monitoring, 1986
- Sodium Valproate and Valpromide: Differential Interactions with Carbamazepine in Epileptic PatientsEpilepsia, 1986
- Carbamazepine-viloxazine interaction in patients with epilepsy.Journal of Neurology, Neurosurgery & Psychiatry, 1986
- Severe carbamazepine intoxication after coadministration of erythromycinThe Journal of Pediatrics, 1986
- Carbamazepine-erythromycin interaction. Case studies and clinical significanceJAMA, 1986
- VERAPAMIL POTENTIATES CARBAMAZEPINE NEUROTOXICITY: A CLINICALLY IMPORTANT INHIBITORY INTERACTIONThe Lancet, 1986
- Clinical Pharmacokinetics and Pharmacological Effects of Carbamazepine and Carbamazepine-10,11-EpoxideClinical Pharmacokinetics, 1986
- Carbamazepine-Erythromycin Interaction Leading to Carbamazepine Toxicity in Four Epileptic ChildrenTherapeutic Drug Monitoring, 1983
- Carbamazepine Intoxication Due to Triacetyloleandomycin Administration in Epileptic PatientsEpilepsia, 1980